Genetic Analysis for Schizophrenia
Palo Alto (17 mi)Overseen byHerbert Y Meltzer, M.D.
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Recruiting
Sponsor: Vanderbilt University
No Placebo Group
Trial Summary
What is the purpose of this trial?The goals of this study are to replicate previous findings of genetic predictors of response to clozapine and other antipsychotic drugs.
Eligibility Criteria
Treatment Details
2Treatment groups
Active Control
Group I: 1 Outcome in schizophrenia with certain antipsychoticActive Control2 Interventions
clozapine
Group II: 2 Outcome in schizophrenia with other AntipsychoticsActive Control2 Interventions
Other Antipsychotics
Find a clinic near you
Research locations nearbySelect from list below to view details:
Psychiatric Hospital at VanderbiltNashville, TN
Loading ...
Who is running the clinical trial?
Vanderbilt UniversityLead Sponsor
Northwestern UniversityLead Sponsor